期刊文献+

乳酸与凝血功能障碍对危重患儿预后的影响 被引量:4

Influence of serum lactic acid and coagulation dysfunction on prognosis in critically ill children patients
下载PDF
导出
摘要 目的研究血乳酸、凝血功能障碍与小儿危重病例评分的关系,及二者对危重患儿预后的影响。方法选取儿童重症监护室(PICU)收治的80例危重患儿资料,按危重病评分(PCIS)标准分为非危重组(n=18)、危重组(n=30)、极危重组(n=32)。比较乳酸、凝血功能指标在不同危重程度患儿中的差异,并进行单因素相关分析、多元线性回归分析。结果随着PCIS的下降,危重患儿病情逐渐加重,休克、多器官功能障碍综合征发生率明显升高。入PICU乳酸值、乳酸峰值、血浆凝血酶原时间、活化部分凝血激酶时间、凝血酶时间、纤维蛋白原与PCIS有显著的线性相关。结论乳酸、凝血功能障碍与PCIS有良好的相关性,二者联合是预测危重患儿预后较敏感的指标。 Objective To investigate the correlation between serum lactic acid (LA) and coagulation dysfunction with pediat- ric critical score (PCIS) and their influence on prognosis in critically ill children patients. Methods Eighty critically ill children pa- tients in the pediatric intensive care unit (PICU)were enrolled and divided into the non-critical (n=18), critical (n= 30) and ex- tremely critical groups (n=32) according to the PCIS standard. Lactic acid (LA) and coagulation function parameters were com- pared among the three groups. The single factor correlation analysis and multiple linear regressive analysis were performed. Results With PCIS decrease, the condition of critically ill children patients was gradually aggravated, the occurrence rates of shock and multiple organ dysfunction syndrome(MODS) were significantly increased. There were significant linear correlation between the lactic acid level,peak lactic acid level,PT,APTT,TT and FBG in PICU with PCIS respectively. Conclusion There is a good corre- lation between serum LA and coagulation dysfunction with PCIS. The combination of serum LA and coagulation dysfunction can be used as a more sensitive indicator for predicting th eprognosis in critically ill children patients.
出处 《重庆医学》 CAS 北大核心 2015年第13期1812-1814,共3页 Chongqing medicine
关键词 危重病人医疗 儿童 乳酸 凝血功能障碍 critical care child lactic acid coagulation dysfunction
  • 相关文献

参考文献14

  • 1Arnold RC,Shapiro NI,Jones AE,et al. Multi center study of early lactate clearance as a determinant of survival in patients with presumed sepsis[J]. Shock,2009,32(1) :35-39.
  • 2Bruno L, Laure OS, Anne MG, et al. Evolution of lactate/ pyruvatend arterial ketone boby rations in the early course of catecholamine-treated septic shock[J]. Crit Care Med, 2000,28(1) : 114-119.
  • 3Levi ML,Schultz M,van der Poll T. Sepsis and thrombo- sis[J]. Semin Thromb Hemost, 2013,39 (5) : 559-566.
  • 4Coletta C, Szabo C. Potential role of hydrogen sulfide in the pathogenesis of vascular dysfunction in septic shock [J]. Curr Vase Pharmacol, 2013,11 (2) : 208-221.
  • 5Martha VF, Gareia PCR, Piva JP, et al. Comparison of two prognostic scores (PRISM and PIM) at a pediatric inten sive care unit [J]. J Pediatr(Rio J), 2005,81 (3) : 259-264.
  • 6Nichol AD, Egi M, Pettila V, et al. Relative hyperlac- tatemia and hospital mortality in critically ill patients: a retrospective multicentre study [J]. Crit Care, 2010, 14 (1):25.
  • 7Jansen TC, van Bommel J, BakkerJ. Blood lactate monito ring in critically ill patients: a systematic health technolo- gy assessment [J]. Crit Care Med, 2009, 37 (10): 2827- 2839.
  • 8Levy B,Gibot S,Franck P,et al. Relation between muscle Na-K-ATPase activity and raised lactate concentrations in septic shock., a prospective study[J]. Lancet, 2005, 365 (9462) :871-875.
  • 9Robergs RA,Ghiasvand F,Parker D. Biochemistry of ex- erciseinduced metabolic acidosis[J].Am J Physiol Regul Integr Comp Physiol,2004,287(3) :R502-516.
  • 10Bakker J,Jansen TC. Don't take vitals take a lactate[J]. Intensive Care Med,2007,33(11) : 1863-1865.

同被引文献32

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部